{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:33:24Z","timestamp":1784637204406,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s43032-020-00257-9","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T19:02:36Z","timestamp":1594407756000},"page":"1812-1820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inhibition of Histone Methyltransferase EZH2 Suppresses Endometriotic Vesicle Development in a Rat Model of Endometriosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Inevy","family":"Seguinot-Tarafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edu","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"Appleyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idhaliz","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"257_CR1","doi-asserted-by":"publisher","unstructured":"Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Vigan\u00f2 P. Endometriosis. Nat Rev. 2018;4(9). https:\/\/doi.org\/10.1038\/s41572-018-0008-5","DOI":"10.1038\/s41572-018-0008-5"},{"issue":"5","key":"257_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0002-9378(25)90629-1","volume":"10","author":"JA Sampson","year":"1925","unstructured":"Sampson JA. Heterotopic or misplaced endometrial tissue. Am J Obstet Gynecol. 1925;10(5):649\u201364.","journal-title":"Am J Obstet Gynecol"},{"key":"257_CR3","first-page":"151","volume":"64","author":"J Halme","year":"1984","unstructured":"Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 1984;64:151\u20134.","journal-title":"Obstet Gynecol"},{"key":"257_CR4","doi-asserted-by":"crossref","unstructured":"Vercellini P, Vigan\u00f2 P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261\u2013275.","DOI":"10.1038\/nrendo.2013.255"},{"issue":"2","key":"257_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/cge.12897","volume":"91","author":"B Borghese","year":"2017","unstructured":"Borghese B, Zondervan KT, Abrao MS, Chapron C, Vaiman D. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet. 2017;91(2):254\u201364.","journal-title":"Clin Genet"},{"issue":"10","key":"257_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/molehr\/gap064","volume":"15","author":"SW Guo","year":"2009","unstructured":"Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587\u2013607.","journal-title":"Mol Hum Reprod"},{"issue":"9","key":"257_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1177\/1933719115578924","volume":"22","author":"M Colon-Caraballo","year":"2015","unstructured":"Colon-Caraballo M, Monteiro JB, Flores I. H3K27me3 is an epigenetic mark of relevance in endometriosis. Reprod Sci. 2015;22(9):1134\u201342.","journal-title":"Reprod Sci"},{"key":"257_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1933719111432870","volume":"19","author":"M Colon-Diaz","year":"2012","unstructured":"Colon-Diaz M, Baez-Vega P, Garcia M, et al. HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod Sci. 2012;19:483\u201392.","journal-title":"Reprod Sci"},{"issue":"3","key":"257_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1933719113497267","volume":"21","author":"B Janice","year":"2014","unstructured":"Janice B, Monteiro MC-D, Garcia M, Gutierrez S, Colon M, Seto E, et al. Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications. Reprod Sci. 2014;21(3):305\u201318.","journal-title":"Reprod Sci"},{"key":"257_CR10","doi-asserted-by":"publisher","unstructured":"Zhang Q, Dong P, Liu X, Sakuragi N, Guo SW. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis. Sci Rep. 2017;7(1):6804. https:\/\/doi.org\/10.1038\/s41598-017-06920-7","DOI":"10.1038\/s41598-017-06920-7"},{"issue":"3","key":"257_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1933719117718275","volume":"25","author":"QZ Xishi Liu","year":"2018","unstructured":"Xishi Liu QZ, Guo S-W. Histological and immunohistochemical characterization of the similarity and difference between ovarian endometriomas and deep infiltrating endometriosis. Reprod Sci. 2018;25(3):329\u201340.","journal-title":"Reprod Sci"},{"key":"257_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1101\/gad.2019811","volume":"25","author":"W-HL Elena Ezhkova","year":"2011","unstructured":"Elena Ezhkova W-HL, Nicole Stokes H, Pasolli A, Silva JM, Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev. 2011;25:485\u201398.","journal-title":"Genes Dev"},{"key":"257_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7150\/ijbs.8.59","volume":"8","author":"L Hennighausen","year":"2012","unstructured":"Hennighausen L, Yoo KH. EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci. 2012;8:59\u201365.","journal-title":"Int J Biol Sci"},{"key":"257_CR14","doi-asserted-by":"publisher","unstructured":"Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani R-S, Tomlins SA, et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 2008;27(58):7274\u201384. https:\/\/doi.org\/10.1038\/onc.2008.333.","DOI":"10.1038\/onc.2008.333"},{"issue":"8","key":"257_CR15","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.18632\/oncotarget.14586","volume":"8","author":"K Ihira","year":"2017","unstructured":"Ihira K, Dong P, Xiong Y, Watari H, Konno Y, Hanley SJB, et al. EZH2 inhibition suppresses endometrial cancer progression via miR-361\/Twist axis. Oncotarget. 2017;8(8):13509\u201320.","journal-title":"Oncotarget"},{"key":"257_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/aps.2013.161","volume":"35","author":"JZYY Tan","year":"2014","unstructured":"Tan JZYY, Wang XX, Jiang Y, Xu HE. EZH2: biology, disease, and structure-based drug discovery. Acta Pharmacol Sin. 2014;35:161\u201374.","journal-title":"Acta Pharmacol Sin"},{"key":"257_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","volume":"6","author":"L Gan","year":"2018","unstructured":"Gan L, Yang Y, Li Q, Feng Y, Liu T, Guo W. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res. 2018;6:10.","journal-title":"Biomark Res"},{"issue":"5","key":"257_CR18","doi-asserted-by":"publisher","first-page":"e98176","DOI":"10.1371\/journal.pone.0098176","volume":"9","author":"CB Nicolas Girard","year":"2014","unstructured":"Nicolas Girard CB, Lhuissier E, Benateau H, Llombart-Bosch A, Boumediene K, Bauge C. 3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells. PLoS One. 2014;9(5):e98176.","journal-title":"PLoS One"},{"key":"257_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/ml3003346","volume":"3","author":"SK Verma","year":"2012","unstructured":"Verma SK, Tian X, LaFrance LV, Duquenne C, Suarez DP, Newlander KA, et al. Tummino, Caretha L. Creasy, and William H. Miller. Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2. ACS Med Chem Lett. 2012;3:1091\u20136.","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"257_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/CAD.0000000000000166","volume":"26","author":"TP Liu","year":"2015","unstructured":"Liu TP, Lo HL, Wei LS, Hsiao HH, Yang PM. S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells. Anti-Cancer Drugs. 2015;26(2):139\u201347.","journal-title":"Anti-Cancer Drugs"},{"issue":"11","key":"257_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nchembio.1084","volume":"8","author":"SKWT Knutson","year":"2012","unstructured":"Knutson SKWT, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR, Sacks JD, et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol. 2012;8(11):890\u20136.","journal-title":"Nat Chem Biol"},{"issue":"13","key":"257_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.4161\/cc.25163","volume":"12","author":"MD Amatangelo","year":"2013","unstructured":"Amatangelo MD, Garipov A, Li H, Conejo-Garcia JR, Speicher DW, Zhang R. Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition. Cell Cycle. 2013;12(13):2113\u20139.","journal-title":"Cell Cycle"},{"key":"257_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/ml3003346","volume":"3","author":"SKTX Verma","year":"2012","unstructured":"Verma SKTX, LaFrance LV, Duquenne C, Suarez DP, Newlander KA, Romeril SP, et al. Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2. ACS Med Chem Lett. 2012;3:1091\u20136.","journal-title":"ACS Med Chem Lett"},{"key":"257_CR24","doi-asserted-by":"publisher","unstructured":"Gulati N, Beguelin W, Giulino-Roth L. Enhancer of zeste homolog 2 (EZH2) inhibitors. Leuk Lymphoma. 2018;59(7):1574\u20131585. https:\/\/doi.org\/10.1080\/10428194.2018.1430795.","DOI":"10.1080\/10428194.2018.1430795"},{"key":"257_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/1440-1681.12382","volume":"42","author":"HZ Muyang Ding","year":"2015","unstructured":"Muyang Ding HZ, Li Z, Wang C, Chen J, Shi L, Xu D, et al. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer. Clin Exp Pharmacol Physiol. 2015;42:458\u201364.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"257_CR26","doi-asserted-by":"publisher","unstructured":"Sato T, Cesaroni M, Chung W, Panjarian S, Tran A, Madzo J, et al. Transcriptional selectivity of epigenetic therapy in cancer. Cancer Res. 2017;77(2):470\u2013481. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0834","DOI":"10.1158\/0008-5472.CAN-16-0834"},{"key":"257_CR27","doi-asserted-by":"publisher","unstructured":"Col\u00f3n-Caraballo M, Torres-Rever\u00f3n A, Soto-Vargas JL, Young SL, Lessey B, Mendoza A, et al. Effects of histone methyltransferase inhibition in endometriosis. Biol Reprod. 2018;99(2):293\u2013307. https:\/\/doi.org\/10.1093\/biolre\/ioy030.","DOI":"10.1093\/biolre\/ioy030"},{"key":"257_CR28","doi-asserted-by":"publisher","unstructured":"Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006;114(3):A160\u2013A167. https:\/\/doi.org\/10.1289\/ehp.114-a160.","DOI":"10.1289\/ehp.114-a160"},{"issue":"8","key":"257_CR29","first-page":"2897","volume":"85","author":"GR Attia","year":"2000","unstructured":"Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab. 2000;85(8):2897\u2013902.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"257_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1055\/s-0029-1242991","volume":"28","author":"SE Bulun","year":"2010","unstructured":"Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med. 2010;28(1):36\u201343.","journal-title":"Semin Reprod Med"},{"issue":"7","key":"257_CR31","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1210\/jc.2009-2713","volume":"95","author":"S Matsuzaki","year":"2010","unstructured":"Matsuzaki S, Darcha C, Maleysson E, Canis M, Mage G. Impaired down-regulation of E-cadherin and beta-catenin protein expression in endometrial epithelial cells in the mid-secretory endometrium of infertile patients with endometriosis. J Clin Endocrinol Metab. 2010;95(7):3437\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"257_CR32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0192623315570339","volume":"43","author":"MC Cora","year":"2015","unstructured":"Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol Pathol. 2015;43:776\u201393.","journal-title":"Toxicol Pathol"},{"issue":"4","key":"257_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/1933719114542022","volume":"22","author":"CB Appleyard","year":"2015","unstructured":"Appleyard CB, Cruz ML, Hernandez S, Thompson KJ, Bayona M, Flores I. Stress management affects outcomes in the pathophysiology of an endometriosis model. Reprod Sci. 2015;22(4):431\u201341.","journal-title":"Reprod Sci"},{"issue":"5","key":"257_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0015-0282(16)48988-0","volume":"44","author":"MW Vernon","year":"1985","unstructured":"Vernon MW, EAW. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684\u201394.","journal-title":"Fertil Steril"},{"key":"257_CR35","doi-asserted-by":"publisher","unstructured":"Ingelmo JMR, Quereda F, Acien P. Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in a murine model. Fertil Steril. 1999;71(5):907\u2013911. https:\/\/doi.org\/10.1016\/s0015-0282(99)00087-4.","DOI":"10.1016\/s0015-0282(99)00087-4"},{"key":"257_CR36","doi-asserted-by":"publisher","unstructured":"Appleyard CB, Cruz ML, Rivera E, Hernandez GA, Flores I. Experimental endometriosis in the rat is correlated with colonic motor function alterations but not with bacterial load. Reprod Sci. 2007;14(8):815\u2013824. https:\/\/doi.org\/10.1177\/1933719107309722.","DOI":"10.1177\/1933719107309722"},{"issue":"1 Pt 1","key":"257_CR37","first-page":"G119","volume":"269","author":"CB Appleyard","year":"1995","unstructured":"Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Phys. 1995;269(1 Pt 1):G119\u201325.","journal-title":"Am J Phys"},{"key":"257_CR38","doi-asserted-by":"publisher","unstructured":"Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, et al. EZH2 Oncogenic activity in castration resistant prostate cancer cells is polycomb-independent. Science. 2012;338(6113):1465\u20131469. https:\/\/doi.org\/10.1126\/science.1227604.","DOI":"10.1126\/science.1227604"},{"issue":"1","key":"257_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/pcmr.12280","volume":"28","author":"J Tiffen","year":"2015","unstructured":"Tiffen J, Gallagher SJ, Hersey P. EZH2: an emerging role in melanoma biology and strategies for targeted therapy. Pigment Cell Melanoma Res. 2015;28(1):21\u201330.","journal-title":"Pigment Cell Melanoma Res"},{"key":"257_CR40","doi-asserted-by":"publisher","unstructured":"Nakagawa S, Okabe H, Sakamoto Y, Hayashi H, Hashimoto D, Yokoyama N, et al. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis. Ann Surg Oncol. 2013;20(3):S667\u2013S675. https:\/\/doi.org\/10.1245\/s10434-013-3135-y.","DOI":"10.1245\/s10434-013-3135-y"},{"issue":"35","key":"257_CR41","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1523\/JNEUROSCI.0538-18.2018","volume":"38","author":"TJ Jarome","year":"2018","unstructured":"Jarome TJ, Perez GA, Hauser RM, Hatch KM, Lubin FD. EZH2 methyltransferase activity controls Pten expression and mTOR signaling during fear memory reconsolidation. J Neurosci. 2018;38(35):7635\u201348.","journal-title":"J Neurosci"},{"issue":"3","key":"257_CR42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/humrep\/der442","volume":"27","author":"C Darcha","year":"2012","unstructured":"Darcha C, Matsuzaki S. Epithelial to mesenchymal transition like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis. Hum Reprod. 2012;27(3):712\u201321.","journal-title":"Hum Reprod"},{"issue":"3","key":"257_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0092-8674(00)80116-6","volume":"86","author":"T Wang","year":"1996","unstructured":"Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, et al. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell. 1996;86(3):435\u201344.","journal-title":"Cell."},{"key":"257_CR44","doi-asserted-by":"crossref","unstructured":"Lee MS. Recent progress in the discovery and development of N-type calcium channel modulators for the treatment of pain. In: Progress in Medicinal Chemistry. Vol 53. Elsevier Elsevier B.V; 2014.","DOI":"10.1016\/B978-0-444-63380-4.00004-4"},{"issue":"10","key":"257_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tins.2013.06.008","volume":"36","author":"D Lipscombe","year":"2013","unstructured":"Lipscombe D, Allen SE, Toro CP. Control of neuronal voltage-gated calcium ion channels from RNA to protein. Trends Neurosci. 2013;36(10):598\u2013609.","journal-title":"Trends Neurosci"},{"key":"257_CR46","doi-asserted-by":"publisher","unstructured":"Godfraind T. Discovery and development of calcium channel blockers. Front Pharmacol. 2017;8(286). https:\/\/doi.org\/10.3389\/fphar.2017.00286.","DOI":"10.3389\/fphar.2017.00286"},{"issue":"1","key":"257_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest. 2014;124(1):30\u20139.","journal-title":"J Clin Invest"},{"key":"257_CR48","doi-asserted-by":"publisher","unstructured":"Italiano A, Soria JC, Toulmonde M, Michot JM, Lucchesi C, Varga A, et al. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study. Lancet Oncol. 2018;19(5):649\u2013659. https:\/\/doi.org\/10.1016\/S1470-2045(18)30145-1.","DOI":"10.1016\/S1470-2045(18)30145-1"},{"key":"257_CR49","doi-asserted-by":"publisher","unstructured":"First EZH2 Inhibitor Approved-for Rare Sarcoma. Cancer Discov. 2020;10(3):333\u2013334. https:\/\/doi.org\/10.1158\/2159-8290.CD-NB2020-006.","DOI":"10.1158\/2159-8290.CD-NB2020-006"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00257-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-020-00257-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00257-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T23:58:54Z","timestamp":1625875134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-020-00257-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1007\/s43032-020-00257-9","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"1 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}